5 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
7 Feb 24
23andMe Reports Third Quarter Fiscal 2024 Financial Results
4:03pm
of African American, Hispanic/Latina, and Asian descent.
Recently announced FDA acceptance of the IND filing for 23ME-01473, a dual-mechanism natural killer
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
1 Sep 23
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
12:00am
occur more often in people of African American and Hispanic/Latino descent
23andMe also granted an FDA Predetermined Change Control Plan, allowing … of occurrence in populations traditionally underserved by genetic testing, including the African American and Hispanic/Latino communities. This marks
DEFR14A
ME
23andMe Holding Co - Ordinary Shares
26 Jul 23
Revised proxy
9:14pm
by design process to ensure the DE&I lens is used throughout the entire product lifestyle.
Our Research team launched our African American Genome … carrier status. This project has been instrumental in building trust with African American partners and consumers.
23andMe Holding Co.
2023 Proxy Statement
DEF 14A
ME
23andMe Holding Co - Ordinary Shares
15 Jul 22
Definitive proxy
8:05am
of Directors
Female
Male
Non-
Binary
Did not
Disclose
Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American
- Prev
- 1
- Next